Aortic DissectionSPIRITNCT06373393
SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique
An observational study of Aortic Dissection and Spinal Cord Ischemia, run by Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA at 1 site in Portugal.
Trial summary
The aim of the study is to evaluate the impact of the stent-assisted balloon-induced intimal disruption and relamination in aortic dissection repair (STABILISE) technique in the patency of intercostal and lumbar arteries detectable on computed tomography angiography (CTA) in patients with type B aortic dissection and… Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Aortic Dissection, Spinal Cord Ischemia
- What is being tested?
- STABILISE
- How many people
- 50 participants
- Where
- 1 sitePortugal
- Study dates
- 16 Apr 2024to 31 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 50 patients with type B aortic dissection submitted to the STABILISE technique
Who may be able to join
- patients with type B dissection treated according to the STABILISE technique
Who cannot join
- Aortic rupture.
Trial locations and contacts
1 site in 1 country.
About this study
The aim of the study is to evaluate the impact of the stent-assisted balloon-induced intimal disruption and relamination in aortic dissection repair (STABILISE) technique in the patency of intercostal and lumbar arteries detectable on computed tomography angiography (CTA) in patients with type B aortic dissection and its correlation with the occurrence of spinal cord ischaemia (SCI).
Primary end-point: patency of the intercostal and lumbar arteries on follow-up CTA.
Secondary end-point: spinal cord ischaemia
Read the detailed description
BACKGROUND AND STUDY INTRODUCTION
Endovascular treatment emerged over the last decade as the standard of care for complicated acute type B aortic dissection and the first step is usually the deployment of a thoracic endograft (TEVAR) aiming to cover the entry tear. TEVAR may be enough to fix malperfusion syndromes but is frequently associated with late aortic dilatation and unfavorable remodeling [1,2]. The failure of simple TEVAR to solve malperfusion syndromes led to the development of adjunctive techniques like direct stenting of the occluded arteries, fenestration of the lamella or the association of a self-expandable bare stent deployment across the visceral and renal arteries to increase the true lumen diameter and improve perfusion of those arteries.
The STABILISE technique to treat type B dissections is able to disrupt the lamella of the dissected aorta and consequently restore the uniluminal state of the aortic anatomy [3,4,5].
The dissection process is related to the detachment of the aortic side branch ostia (visceral, renal, iliacs, intercostals, lumbars) and therefore a potential status of malperfusion which is often related to severe clinical complications that should be properly managed. Additionally, when the lamella is brought back to the peripheral aortic wall, according to the STABILISE concept, the recovery of perfusion from the true lumen is unclear.
All these mechanisms, as well as the cover of the ostia of upper intercostal arteries by the stentgraft, may compromise the intercostal and lumbar arteries patency or the direct flow from the true lumen and therefore be related to the occurrence of spinal cord ischemia complications which prevalence was not yet determined [6-10].
FEASIBILITY AND PRELIMINARY DATA
Our research group carried out a pilot study, accepted for publication in the journal "Journal of Vascular Surgery Cases, Innovations and Techniques", on patency of intercostal arteries after treatment of type B aortic dissection with the STABILIZE technique. In this study, we observed a decrease in the permeability of the intercostal arteries in the area of the thoracic endoprosthesis, but we concluded that the permeability of the spinal arteries was not significantly affected by the coverage of the aorta with the uncovered stent nor by its aggressive ballooning to replace the intimal lamella. These findings constitute a step towards a better understanding of the safety of this technique.
STUDY DESIGN AND METHODS
This is a multi-center, non-randomized, retrospective observational analysis of patients treated with STABILISE technique for type B aortic dissection.
The following data will be collected:
- preoperative comorbidities.
- temporal phase of dissection (hyperacute, acute, subacute or chronic).
- procedural data (diameter and length of the stentgraft(s) and bare stent(s) and length of the covered aorta.
- occurrence of SCI at discharge and 30 days after procedure, according to the TARLOV scale.
Contrast-enhanced thoraco-abdominal CTA will be performed to patients pre-operatively and within 1 month, 6 months and yearly after the procedure.
Inclusion criteria
All patients with ≥ 18 years of age, with a type B dissection, treated according to the STABILISE technique
Exclusion criteria
- Aortic rupture.
CTA protocol Contrast-enhanced thoraco-abdominal CTA (with thin slices, preferably 1mm) will be performed to all patients pre-operatively and within 1 month, 6 months and then yearly after the procedure. Axial, coronal and column curvature based maximum intensity projections (MIP) with 10mm slice thickness will be performed and analyzed retrospectively.
After removing any patient's identification, the DICOM data will be sent, via WeTransfer, to the analysis center in Lisbon where the quantification and patency analysis will be performed.
Results evaluation The CTA images will be semi-quantitatively analyzed by two independent investigators and the number of visible intercostal and lumbar arteries in the stented aorta (stent-graft and dilated bare metal stent) will be evaluated.
The following parameters will be analyzed and reported in the attached sheet:
PRE-TREATMENT CTA
- Presence and patency of the intercostal and lumbar arteries specifying right and left sides.
- Origin of the intercostal and lumbar arteries - true lumen, false lumen (FL), both - specifying right and left sides
POST-TREATMENT CTA's
- Presence and patency of the intercostal and lumbar arteries (specifying right and left sides).
- Origin of the intercostal and lumbar arteries (TL, FL, both) in cases where the uniluminal state was not completely restored (specifying right and left sides).
- Patency of the distal portion of the intercostal and lumbar arteries when the ostium was covered by the stentgraft (specifying right and left sides).
- Patency of the intercostal and lumbar arteries in the area of the bare stent (specifying right and left sides).
- Patency of the intercostal and lumbar arteries in the area distal to the bare stent (specifying right and left sides).
All the assessed variables will be collected at the coordinating Center (Santa Maria Hospital), using the image data provided by the two participating centers.
- Conditions
- Aortic Dissection, Spinal Cord Ischemia
- Being tested
- STABILISE
- Keywords
- aortic dissection, STABILISE, spinal cord ischemia, bare stent, stent-graft, endovascular repair
- Medical subject headings
- Aortic Dissection, Spinal Cord Ischemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
STABILISEOther
STABILISE technique: "Stent assisted balloon induced intimal disruption and relamination in aortic dissection repair"
What is being measured
The primary outcome is the main question the study is designed to answer.
number of patent intercostal and lumbar arteries
number of patent intercostal and lumbar arteries after STABILISE
Measured: baseline (pre op) and 1, 6, 12 and 24 months after surgery
Secondary outcomes (1)
number of patients with spinal cord ischemia
number of patients with spinal cord ischemia after STABILISE
Measured: baseline (pre op) and 1month after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Apr 2024
- Study start16 Apr 2024
- Primary completion31 Jul 2024 (estimated)
- Study completion31 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Aortic DissectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
- Sponsor type
- University, hospital or other
- Collaborators
- Cardiovascular Center of the University of Lisbon, Unidade Local de Saúde Santa Maria
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06373393
- Sponsor's protocol ID
- 1
- Acronym
- SPIRIT
- Status last verified
- Apr 2024
- First submitted
- 16 Apr 2024
- Last updated
- 22 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique
- ClinicalTrials.gov ID
- NCT06373393
- Acronym / sponsor ID
- SPIRIT / 1
- Conditions
- Aortic Dissection, Spinal Cord Ischemia
- Keywords
- aortic dissection, STABILISE, spinal cord ischemia, bare stent, stent-graft, endovascular repair
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERAUniversity, hospital or other
- Collaborators
- Cardiovascular Center of the University of Lisbon, Unidade Local de Saúde Santa Maria
- Study start
- 16 Apr 2024 (actual)
- Primary completion
- 31 Jul 2024 (estimated)
- Study completion
- 31 Dec 2024 (estimated)
- First posted
- 18 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to evaluate the impact of the stent-assisted balloon-induced intimal disruption and relamination in aortic dissection repair (STABILISE) technique in the patency of intercostal and lumbar arteries detectable on computed tomography angiography (CTA) in patients with type B aortic dissection and its correlation with the occurrence of spinal cord ischaemia (SCI).
Primary end-point: patency of the intercostal and lumbar arteries on follow-up CTA.
Secondary end-point: spinal cord ischaemia
Detailed description
BACKGROUND AND STUDY INTRODUCTION
Endovascular treatment emerged over the last decade as the standard of care for complicated acute type B aortic dissection and the first step is usually the deployment of a thoracic endograft (TEVAR) aiming to cover the entry tear. TEVAR may be enough to fix malperfusion syndromes but is frequently associated with late aortic dilatation and unfavorable remodeling [1,2]. The failure of simple TEVAR to solve malperfusion syndromes led to the development of adjunctive techniques like direct stenting of the occluded arteries, fenestration of the lamella or the association of a self-expandable bare stent deployment across the visceral and renal arteries to increase the true lumen diameter and improve perfusion of those arteries.
The STABILISE technique to treat type B dissections is able to disrupt the lamella of the dissected aorta and consequently restore the uniluminal state of the aortic anatomy [3,4,5].
The dissection process is related to the detachment of the aortic side branch ostia (visceral, renal, iliacs, intercostals, lumbars) and therefore a potential status of malperfusion which is often related to severe clinical complications that should be properly managed. Additionally, when the lamella is brought back to the peripheral aortic wall, according to the STABILISE concept, the recovery of perfusion from the true lumen is unclear.
All these mechanisms, as well as the cover of the ostia of upper intercostal arteries by the stentgraft, may compromise the intercostal and lumbar arteries patency or the direct flow from the true lumen and therefore be related to the occurrence of spinal cord ischemia complications which prevalence was not yet determined [6-10].
FEASIBILITY AND PRELIMINARY DATA
Our research group carried out a pilot study, accepted for publication in the journal "Journal of Vascular Surgery Cases, Innovations and Techniques", on patency of intercostal arteries after treatment of type B aortic dissection with the STABILIZE technique. In this study, we observed a decrease in the permeability of the intercostal arteries in the area of the thoracic endoprosthesis, but we concluded that the permeability of the spinal arteries was not significantly affected by the coverage of the aorta with the uncovered stent nor by its aggressive ballooning to replace the intimal lamella. These findings constitute a step towards a better understanding of the safety of this technique.
STUDY DESIGN AND METHODS
This is a multi-center, non-randomized, retrospective observational analysis of patients treated with STABILISE technique for type B aortic dissection.
The following data will be collected:
- preoperative comorbidities.
- temporal phase of dissection (hyperacute, acute, subacute or chronic).
- procedural data (diameter and length of the stentgraft(s) and bare stent(s) and length of the covered aorta.
- occurrence of SCI at discharge and 30 days after procedure, according to the TARLOV scale.
Contrast-enhanced thoraco-abdominal CTA will be performed to patients pre-operatively and within 1 month, 6 months and yearly after the procedure.
Inclusion criteria
All patients with ≥ 18 years of age, with a type B dissection, treated according to the STABILISE technique
Exclusion criteria
- Aortic rupture.
CTA protocol Contrast-enhanced thoraco-abdominal CTA (with thin slices, preferably 1mm) will be performed to all patients pre-operatively and within 1 month, 6 months and then yearly after the procedure. Axial, coronal and column curvature based maximum intensity projections (MIP) with 10mm slice thickness will be performed and analyzed retrospectively.
After removing any patient's identification, the DICOM data will be sent, via WeTransfer, to the analysis center in Lisbon where the quantification and patency analysis will be performed.
Results evaluation The CTA images will be semi-quantitatively analyzed by two independent investigators and the number of visible intercostal and lumbar arteries in the stented aorta (stent-graft and dilated bare metal stent) will be evaluated.
The following parameters will be analyzed and reported in the attached sheet:
PRE-TREATMENT CTA
- Presence and patency of the intercostal and lumbar arteries specifying right and left sides.
- Origin of the intercostal and lumbar arteries - true lumen, false lumen (FL), both - specifying right and left sides
POST-TREATMENT CTA's
- Presence and patency of the intercostal and lumbar arteries (specifying right and left sides).
- Origin of the intercostal and lumbar arteries (TL, FL, both) in cases where the uniluminal state was not completely restored (specifying right and left sides).
- Patency of the distal portion of the intercostal and lumbar arteries when the ostium was covered by the stentgraft (specifying right and left sides).
- Patency of the intercostal and lumbar arteries in the area of the bare stent (specifying right and left sides).
- Patency of the intercostal and lumbar arteries in the area distal to the bare stent (specifying right and left sides).
All the assessed variables will be collected at the coordinating Center (Santa Maria Hospital), using the image data provided by the two participating centers.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 50 patients with type B aortic dissection submitted to the STABILISE technique
Key inclusion criteria (1 listed)
- patients with type B dissection treated according to the STABILISE technique
Key exclusion criteria (1 listed)
- Aortic rupture.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| STABILISESTABILISE technique: "Stent assisted balloon induced intimal disruption and relamination in aortic dissection repair" | Other | – |
Primary outcome
number of patent intercostal and lumbar arteries
Time frame: baseline (pre op) and 1, 6, 12 and 24 months after surgery
number of patent intercostal and lumbar arteries after STABILISE
1 secondary outcome
number of patients with spinal cord ischemia
Time frame: baseline (pre op) and 1month after surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Apr 2024.
- Individual participant dataSharing planned: No
Related trials for Aortic Dissection
Not yet recruitingPhase 2
D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Not yet recruitingObservational study
Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices
Aortic Aneurysm and Dissection
Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Aortic Arch Dissection, Aortic Arch Aneurysm
RecruitingObservational study
Metabolic Phenotyping in vEDS
Vascular Ehlers-Danlos Syndrome, Vascular Ehlers Danlos Syndrome
Not yet recruitingObservational study
Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.
Complex Aortic Aneurysms, Thoracoabdominal Aneurysm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Aortic Dissection and Spinal Cord Ischemia, run by Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
number of patent intercostal and lumbar arteries (time frame: baseline (pre op) and 1, 6, 12 and 24 months after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2024.